1 Percutaneous Ablation of Renal Cell Carcinoma

2016 ◽  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Percutaneous Ablation

Imaging-Guided Percutaneous Ablation of Renal Cell Carcinoma: A Primer of How We Do It

2009 ◽  
Vol 192 (6) ◽  
pp. 1558-1570 ◽  
Author(s):  
Raul N. Uppot ◽  
Stuart G. Silverman ◽  
Ronald J. Zagoria ◽  
Kemal Tuncali ◽  
David D. Childs ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Percutaneous Ablation

scholarly journals Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma

2020 ◽  
Vol 31 (2) ◽  
pp. 189-194.e3 ◽  
Author(s):  
Christopher S. Morris ◽  
Mark O. Baerlocher ◽  
Sean R. Dariushnia ◽  
Eric D. McLoney ◽  
Nadine Abi-Jaoudeh ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Interventional Radiology ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Position Statement ◽  
Percutaneous Ablation

scholarly journals Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature

2018 ◽  
Vol 12 (1) ◽  
pp. 43-49 ◽  
Author(s):  
Andrew J. Gunn ◽  
Benjamin J. Mullenbach ◽  
May M. Poundstone ◽  
Jennifer B. Gordetsky ◽  
Edgar S. Underwood ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Arterial Embolization ◽  
Common Femoral Artery ◽  
Percutaneous Ablation ◽  
Tumor Diameter ◽  
Technical Aspects ◽  
Ethiodized Oil ◽  
Embolic Materials

This report describes the technical aspects of trans-arterial embolization (TAE) of renal cell carcinoma prior to percutaneous ablation. All patients (n = 11) had a single renal mass (mean tumor diameter = 50.2 mm; range: 28-84 mm). Selective TAE was performed via the common femoral artery. Embolic materials included: particles alone (n = 4), coils alone (n = 1), particles + ethiodized oil (n = 2), particles + coils (n = 1), ethiodized oil + ethanol (n = 2), and particles + ethanol (n = 1). All embolizations were technically successful and no complications have been reported. After embolization, 10 patients underwent cryoablation while 1 patient underwent microwave ablation. Ablations were technically successful in 10 of the 11 patients. Only 3 minor complications were identified but none required treatment. No adverse effect on the patient's glomerular filtration rate was seen from the additional procedure (p = 0.84). TAE of renal cell carcinoma prior to percutaneous ablation is safe and technically-feasible.

scholarly journals Percutaneous ablation techniques for renal cell carcinoma: current status and future trends

2019 ◽  
Vol 36 (2) ◽  
pp. 21-30 ◽  
Author(s):  
D. Filippiadis ◽  
G. Mauri ◽  
P. Marra ◽  
G. Charalampopoulos ◽  
N. Gennaro ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Ablation Techniques ◽  
Current Status ◽  
Percutaneous Ablation ◽  
Future Trends

scholarly journals Pneumodissection during Percutaneous Renal Ablation Resulting in Air Embolism: Percutaneous Management and a Review of the Literature

2019 ◽  
Vol 36 (02) ◽  
pp. 120-125
Author(s):  
Kamil Arif ◽  
Andrew J. Gunn
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Air Embolism ◽  
Percutaneous Ablation ◽  
Review Of The Literature ◽  
Renal Ablation ◽  
Nephron Sparing ◽  
Collecting System ◽  
Urinary Collecting System

AbstractPercutaneous renal ablation is a nephron-sparing approach for selected patients with renal cell carcinoma. Common complications include hemorrhage, injury to the urinary collecting system, and abscess formation. The purpose of this article is to present a case of vascular air embolism as a complication of pneumodissection performed during percutaneous ablation of renal cell carcinoma, discuss its successful percutaneous management, review common complications of renal ablation, and outline steps physicians can take to lessen these complications.

CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma

2016 ◽  
Vol 40 (2) ◽  
pp. 177-191 ◽  
Author(s):  
Miltiadis E. Krokidis ◽  
Franco Orsi ◽  
Konstantinos Katsanos ◽  
Thomas Helmberger ◽  
Andy Adam
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Percutaneous Ablation ◽  
Cirse Guidelines

scholarly journals Percutaneous Cryoablation for Renal Cell Carcinoma

2015 ◽  
Vol 2 (3) ◽  
pp. 105-113 ◽  
Author(s):  
Tsitskari Maria ◽  
Christos Georgiades
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Early Stage ◽  
Imaging Techniques ◽  
Percutaneous Ablation ◽  
Renal Masses ◽  
Cross Sectional ◽  
Percutaneous Cryoablation ◽  
Nephron Sparing

Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. Nephron sparing resection (partial nephrectomy) has been the “gold standard” for the treatment of resectable disease. With the widespread use of cross sectional imaging techniques, more cases of renal cell cancers are detected at an early stage, i.e. stage 1A or 1B.  This has provided an impetus for expanding the nephron sparing options and especially, percutaneous ablative techniques.  Percutaneous ablation for RCC is now performed as a standard therapeutic nephron-sparing option in patients who are poor candidates for resection or when there is a need to preserve renal function due to comorbid conditions, multiple renal cell carcinomas, and/or heritable renal cancer syndromes. During the last few years, percutaneous cryoablation has been gaining acceptance as a curative treatment option for small renal cancers. Clinical studies to date indicate that cryoablation is a safe and effective therapeutic method with acceptable short and long term outcomes and with a low risk, in the appropriate setting.  In addition it seems to offer some advantages over radio frequency ablation (RFA) and other thermal ablation techniques for renal masses.

Sign in / Sign up

Export Citation Format

Share Document